Prostaglandin Analogues – SCCS Final Opinion

Prostaglandin Analogues – SCCS Final Opinion

On 10th of February 2026, the Scientific Committee on Consumer Safety (SCCS) concluded that certain prostaglandin analogues are not considered safe for use in eyebrow and eyelash growth products, based on available research, although non-genotoxic carcinogenicity...
Prostaglandin Analogues – SCCS Final Opinion

Prostaglandin Analogues – Draft SCCS Opinion

Summary: Substance: Prostaglandin AnaloguesEffected Products: Eyelash and eyebrow growth productsDate of Implementation: Unapplicable, SCCS Opinion stage On 6 June 2025, the Scientific Committee on Consumer Safety (SCCS) released its draft opinion concerning...
New SCCS Mandate for Prostaglandin Analogues

New SCCS Mandate for Prostaglandin Analogues

On 27 March 2024, the Scientific Committee on Consumer Safety (SCCS) adopted a new mandate to review the safety of prostaglandin analogues (ethyl tafluprostamide – DDDE, methylamido-dihydro-noralfaprostal – MDN, and isopropyl cloprostenate – IPCP) in...